Indication
Chimeric Antigen Receptor T-cell Therapy Targeting CD19
1 clinical trial
1 product
Clinical trial
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2028-12-31
Product
SNUH-CD19-CAR-T